No data available.
Please log in to see this content.
You have no subscription access to this content.
No metrics data to plot.
The attempt to load metrics for this article has failed.
The attempt to plot a graph for these metrics has failed.
The full text of this article is not currently available.
Radiotherapy is an appropriate treatment to consider for patients infected with the Ebola virus
1.M. Mohamadzadeh, L. Chen, and A. L. Schmaljohn, “How Ebola and Marburg viruses battle the immune system,” Nat. Rev. Immunol. 7, 556–567 (2007).
3.R. Corvo, M. Zeverino, S. Vagge, S. Agostinelli, S. Barra, G. Taccini, M. T. Van lint, F. Frassoni, and A. Bacigalupo, “Helical tomotherapy targeting total bone marrow after total body irradiation for patients with relapsed acute leukemia undergoing an allogeneic stem cell transplant,” Radiother. Oncol. 98, 382–386 (2011).
4.A. Gruen, W. Ebell, W. Wlodarczyk, O. Neumann, J. S. Kuehl, C. Stromberger, V. Budach, and S. Marnitz, “Total body irradiation (TBI) using helical tomotherapy in children and young adults undergoing stem cell transplantation,” Radiat. Oncol. 8(92) (8pp.) (2013).
6.T. W. Geisbert, H. A. Young, P. B. Jahrling, K. J. Davis, T. Larsen, E. Kagan, and L. E. Hensley, “Pathogenesis of Ebola hemorrhagic fever in primate models: Evidence that hemorrhage is not a direct effect of virus-induced cytolysis of endothelial cells,” Am. J. Pathol. 163, 2371–2382 (2003).
7.A. H. Zhuang, A. Liu, T. E. Schultheiss, and J. Y. Wong, “Dosimetric study and verification of total body irradiation using helical tomotherapy and its comparison to extended SSD technique,” Med. Dosim. 35, 243–249 (2010).
8.E. Dadachova, S. G. Kitchen, G. Bristol, G. C. Baldwin, E. Revskaya, C. Empig, G. B. Thornton, M. K. Gorny, S. Zolla-Pazner, and A. Casadevall, “Pre-clinical evaluation of a 213Bi-labeled 2556 antibody to HIV-1 gp41 glycoprotein in HIV-1 mouse models as a reagent for HIV eradication,” PLoS One 7, e31866(9pp.) (2012).
9.X. Qiu, J. Audet, G. Wong, S. Pillet, A. Bello, T. Cabral, J. E. Strong, F. Plummer, C. R. Corbett, J. B. Alimonti, and G. P. Kobinger, “Successful treatment of Ebola virus-infected cynomolgus macaques with monoclonal antibodies,” Sci. Transl. Med. 4, 138ra181(13pp.) (2012).
10.M. Abdel-Wahab, J.-M. Bourque, Y. Pynda, J. Iżewska, D. Van der Merwe, E. Zubizarreta, and E. Rosenblatt, “Status of radiotherapy in Africa: An International Atomic Energy Agency analysis,” Lancet Oncol. 14(4), e168–e175 (2013).
11.G. Delaney, S. Jacob, C. Featherstone, and M. Barton, “The role of radiotherapy in cancer treatment: Estimating optimal utilization from a review of evidence-based clinical guidelines,” Cancer 104(6), 1129–1137 (2005).
14.S. Reardon, “Ebola treatments caught in limbo: Logistics and lack of funds keep experimental drugs and vaccines from being used in Africa outbreak,” Nature 511, 520 (2014).
18.R. M. Macklis, M. Kalaycio, R. Sobecks, P. Pohlman, S. S. Brown, and B. Bolwell, “Low dose total body irradiation (TBI) in outpatient non-myeloablative bone marrow transplantation,” Int. J. Radiat. Oncol., Biol., Phys. 57, S292 (2003).
20.K. Feng, E. Divers, Y. Ma, and J. Li, “Inactivation of a human norovirus surrogate, human norovirus virus-like particles, and vesicular stomatitis virus by gamma irradiation,” Appl. Environ. Microbiol. 77(10), 3507–3517 (2011).
22.S. Burdach et al., “High-dose therapy for patients with primary multifocal and early relapsed Ewing’s tumors: Results of two consecutive regimens assessing the role of total-body irradiation,” Int. J. Clin. Oncol. 21(16), 3072–3078 (2003).
25.G. Kohler and C. Milstein, “Continuous cultures of fused cells secreting antibody of predefined specificity,” Nature 256, 495–497 (1975).
26.A. Casadevall, E. Dadachova, and L. A. Pirofski, “Passive antibody therapy for infectious disease,” Nat. Rev. Microbiol. 2, 695–703 (2004).
Article metrics loading...
There is no abstract available for this article.
Full text loading...
Most read this month